Kraj: Wielka Brytania
Język: angielski
Źródło: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cefalexin
Alliance Healthcare (Distribution) Ltd
J01DB01
Cefalexin
500mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010201
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet.You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or dentist (if the medicine has been prescribed by your dentist). • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, pharmacist or dentist (if the medicine has been prescribed by your dentist). IN THIS LEAFLET: 1. WHAT CEFALEXIN TABLETS ARE AND WHAT THEY ARE USED FOR 2. BEFORE YOU TAKE CEFALEXIN TABLETS 3. HOW TO TAKE CEFALEXIN TABLETS 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE CEFALEXIN TABLETS 6. FURTHER INFORMATION 1 . WHAT CEFALEXIN TABLETS ARE AND WHAT THEY ARE USED FOR The name of your medicine is Cefalexin Tablets. This medicine belongs to a family of medicines called antibiotics. Antibiotics are used to kill the bacteria or “germs” which cause infections. Your doctor, or dentist, will have prescribed this medicine for treating an infection. Cefalexin Tablets are used for treating a variety of infections including chest (respiratory tract), urinary tract, skin and soft tissues, ear, and other infections. 2. BEFORE YOU TAKE CEFALEXIN TABLETS DO NOT TAKE THIS MEDICINE BEFORE TELLING YOUR DOCTOR IF: • You are allergic to cefalexin or other antibiotics and medicines. • You are allergic to any of the other ingredients in this medicine. TAKE SPECIAL CARE WITH CEFALEXIN TABLETS: • You are pregnant or breast-feeding. Your doctor will decide whether it is safe for you to take this medicine while you are pregnant or breast-feeding. • You have problems with your kidneys. • You test your urine for glucose using a method which is not based on glucose oxidation reactions as this medicine might give a false positive result. • You are taking oral contraceptives. Cefalexin may reduce the efficacy of or Przeczytaj cały dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cefalexin 500mg Tablets; Tenkorex Tablets 500mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Cefalexin BP equivalent to 500 mg anhydrous cefalexin. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablets. Oblong, biconvex, white to yellowish. Scored on both sides. Odour - slightly peppermint to characteristic of the active ingredient. 4 CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Tenkorex/Cefalexin 500mg tablets is indicated for the treatment of respiratory tract infections (RTI's), urinary tract infections (UTI's), skin and soft tissue infections, otitis media and other infections due to sensitive organisms 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults _ The dosage is 1-4 g daily in divided doses. Most infections will respond to 500 mg every 8 hours. For skin and soft tissue infections, streptococcal pharyngitis and mild uncomplicated UTI's, the usual dosage is 250 mg every 6 hours or 500 mg every 12 hours. For more severe infections or those caused by less susceptible organisms, larger doses may be needed. _Older people _ The dosage is as for adults. The dosage should be reduced if renal function is markedly impaired. _Paediatric population and adolescents _ The usual recommended daily dosage for children is 25-50 mg/kg in divided doses. For skin and soft tissue infections, streptococcal pharyngitis and mild, uncomplicated urinary tract infections, the total daily dose may be divided and administered every 12 hours. For most infections the following schedule is suggested: children under 5 years: 125 mg every 8 hours children 5 years and over: 250 mg every 8 hours In severe infections the dosage may be doubled. In the therapy of otitis media, clinical studies have shown that a dosage of 75-100mg/kg/day in 4 divided doses is required. In the treatment of beta-haemolytic streptococcal infections, a therapeutic dose should be administered for at least 10 days. Method of admini Przeczytaj cały dokument